Year in review: EmVenio in 2025
From a rebrand to clinical trial facilitation to the conference circuit, EmVenio covered a lot of ground. Here are some…
Partner Content
-
-
Trends for 2026: Targeted AI, continuous trials, and navigating uncertainty
As the clinical trial industry faces key challenges such as shifts, rising costs, and staffing challenges, 2026 is poised to…
-
Vertically integrated CDMOs: The advantages and disadvantages for ADCs
Vertical integration of contract development and manufacturing organisations (CDMOs) involved in antibody-drug conjugates (ADCs) manufacturing has the potential to streamline…
-
Potency assays in cell therapies: A look behind the challenges
Dr. Scott Jones has spent more than 35 years advancing assay development and currently leads BioBridge Global’s R&D department. His…
-
Emerging trends in real-world data and AI’s expanding role
Real-world data (RWD) is transforming healthcare by the changing priorities of pharma companies and the growing influence of AI, with…
-
The value of real-world data for healthcare marketing
Marketing has evolved significantly since the time when a marketing plan would ignore market segment differences and appeal to the…
-
Clinical trial predictions and the role of technology in 2026
Looking ahead to 2026, the clinical research landscape is entering a pivotal phase. As trial design innovations, hybrid studies, and…
-
Live Biotherapeutic Products Whitepaper 2025
Growth in LBP production can be attributed to well-defined regulatory pathways in regions such as the US and EU, advancements…
-
Meet the new EmVenio in 2026
Clinical research is evolving, but access to trials remains uneven. Many patients still face barriers to participation, and sponsors are…
-
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
Author: Manny Vazquez, Senior Director Clinical Data Strategy, Veeva The number of data points collected in clinical trials has tripled…